Tratamento do câncer cervical
Palavras-chave:
colo uterino, câncer, tratamento, radioterapiaReferências
Hill EK. Updates in Cervical Cancer Treatment. Clin Obstet Gynecol. 2020 Mar;63(1):3-11. doi: 10.1097/GRF.0000000000000507. PMID: 31815773.
Bhatla N, Aoki D, Sharma DN, et al. FIGO Cancer Report 2018: cancer of the cervix uteri. Int J Gynecol Obstet. 2018;143(suppl 2):22–36.
Matuso K, Machida H, Mandelbaum RS, et al. Validation of the 2018 FIGO cervical cancer staging system. Gynecol Oncol. 2019;152:87–93.
Berek JS, Matuso K, Grubbs BH, et al. Multidisciplinary perspectives on newly revise 2018 FIGO staging of cancer of the cerxi uteri. J Gynecol Oncol. 2019;30:e40.
Lanciano R, Calkins A, Bundy BN, et al. Randomized comparision of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervical cancer: a gynecologic oncology group study. J Clin Oncol. 2005;23:8289–8295.
Havrilesky LJ, Kulasingam SL, Matchar DB, et al. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol. 2005;97:183–191.
Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379:1895–1904.
Tan LT, Tanderup K, Kirisits C, et al. Image guided adaptive radiotherapy in cervical cancer. Semin Radiat Oncol. 2019;29:284–298.
Tewari KS, Sill MW, Long HJ, et al. Improved suvival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370:734–743.
Chung HC, Ros W, Delord JP, et al. Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol. 2019;37:1470–1478.
